Realtime | Geld | Brief | Zeit |
---|---|---|---|
0,680 | 0,740 | 23.01. |
Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
NANOVIBRONIX Aktie jetzt für 0€ handeln | |||||
Do | NanoVibronix stock touches 52-week low at $0.44 amid market challenges | 1 | Investing.com | ||
14.01. | NanoVibronix-Aktie erreicht 52-Wochen-Tief bei 0,46 US-Dollar | 1 | Investing.com Deutsch | ||
14.01. | NanoVibronix stock touches 52-week low at $0.46 amid market challenges | 1 | Investing.com | ||
07.01. | NanoVibronix erzielt Fortschritte bei der Entwicklung medizinischer Geräte | 3 | Investing.com Deutsch | ||
07.01. | NanoVibronix advances medical device development | 3 | Investing.com | ||
06.01. | NanoVibronix completes pilot study of UroShield | 1 | MassDevice | ||
06.01. | NanoVibronix, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
19.12.24 | NanoVibronix stock touches 52-week low at $0.46 amid market challenges | 8 | Investing.com | ||
19.12.24 | NanoVibronix, Inc. - 8-K, Current Report | - | SEC Filings | ||
11.12.24 | NanoVibronix, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
11.12.24 | NanoVibronix renews distribution agreement with Ultra Pain Products | 3 | Seeking Alpha | ||
11.12.24 | NanoVibronix renews distribution with UPPI through 2029 | 1 | Investing.com | ||
22.11.24 | NanoVibronix, Inc. - 8-K, Current Report | - | SEC Filings | ||
14.11.24 | NanoVibronix, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
12.11.24 | NanoVibronix expands global reach, eyes new markets | 3 | Investing.com | ||
12.11.24 | NanoVibronix, Inc.: NanoVibronix Provides Business Update | 212 | Business Wire | NanoVibronix, Inc.(NASDAQ: NAOV) (the "Company"), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic... ► Artikel lesen | |
14.10.24 | NanoVibronix faces potential Nasdaq delisting | 2 | Investing.com | ||
14.10.24 | NanoVibronix droht Delisting von der Nasdaq | 1 | Investing.com Deutsch | ||
07.10.24 | NanoVibronix, Inc. - 8-K, Current Report | - | SEC Filings | ||
26.09.24 | NanoVibronix extends CEO and CFO contracts with new terms | 2 | Investing.com |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIEMENS HEALTHINEERS | 54,34 | +0,70 % | Siemens Healthineers-Aktie: Kurs klettert leicht (53,42 €) | Am deutschen Aktienmarkt liegt das Wertpapier von Siemens Healthineers aktuell im Plus. Die Aktie kostete zuletzt 53,42 Euro. Die Aktie von Siemens Healthineers verzeichnet gegenwärtig einen Wertanstieg... ► Artikel lesen | |
MEDTRONIC | 85,68 | +1,53 % | Medtronic Appoints Thierry Pieton As CFO | WASHINGTON (dpa-AFX) - Medtronic Plc (MDT), a healthcare technology company, said on Tuesday that it has appointed Thierry Pieton as its Chief Financial Officer with effect from March 3. Pieton... ► Artikel lesen | |
INTUITIVE SURGICAL | 584,00 | -0,41 % | Soll ich diese Aktien jetzt kaufen? Intel, Intuitive Surgical und UnitedHealth im Check | Soll ich diese Aktien jetzt kaufen? Intel, Intuitive Surgical und UnitedHealth im Chec ► Artikel lesen | |
BIOTEST | 26,800 | -0,37 % | Aktien KW 2 - US-Jobmarkt verdirbt die Party? Woche mit Paukenschlag. News. Auto1. Mutares. Nvidia. Kion. Magirus. Fuchs. INDUS. Biotest. Circus | Aktien Wochenrückblick - nach zwei ruhigen feiertagsgeprägten Wochen sah es diese Woche wieder so aus, als ob der DAX wieder auf Rekordkurs gehen wollte. Angebrannt ist nichts, aber die US-Jobdaten... ► Artikel lesen | |
ROKU | 80,61 | +5,46 % | Roku Stock Sees RS Rating Climb To 79 | ||
BECTON DICKINSON | 230,70 | +0,96 % | BD And Biosero Partner To Integrate Robotics With Flow Cytometry | WASHINGTON (dpa-AFX) - BD. (BDX), a global medical technology company, and Biosero, a developer of laboratory automation solutions, Thursday announced that they have entered into a framework... ► Artikel lesen | |
DEXCOM | 83,50 | -0,16 % | Dexcom CEO says 2025 is 'shaping up to be a good year' with Stelo launch, GenAI integration | ||
ALIGN TECHNOLOGY | 224,70 | +0,76 % | The Analyst Verdict: Align Tech In The Eyes Of 3 Experts | ||
BAXTER | 31,165 | +1,96 % | Bear of the Day: Baxter (BAX) | ||
ATOSSA THERAPEUTICS | 0,911 | -1,62 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Issues Letter to Shareholders Highlighting 2024 Accomplishments and Outlook for 2025 | SEATTLE, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment... ► Artikel lesen | |
DAVITA | 163,00 | +0,71 % | DaVita stock soars to all-time high of $169.54 amid robust growth | ||
SPINEWAY | 0,101 | -24,91 % | Spineway: 2024 revenue of €12 million - 14% growth compared with 2023 | Press release Ecully, January 22, 2025 - 6.30 p.m. SPINEWAY 2024 revenue of €12 million 14% growth compared with 2023 In thousands of euros20242023Change as a %H1 revenue6,5355,431+20%H2... ► Artikel lesen | |
SONOMA PHARMACEUTICALS | 2,520 | 0,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices | BOULDER, CO / ACCESSWIRE / December 5, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen | |
ORGANON | 15,565 | +2,03 % | Organon & Co. - 8-K, Current Report | ||
CO-DIAGNOSTICS | 0,775 | -3,73 % | Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results | SALT LAKE CITY, Nov. 7, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen |